16.2 Documentation, Laws & Regulatory Agencies
Key Takeaways
- Document insertions, assessments, complications, and teaching accurately and in a timely way; never chart ahead of care—legal defensibility depends on contemporaneous truthfulness.
- OSHA governs workplace safety including bloodborne pathogens, sharps injury prevention, and hazardous drug exposure expectations; NIOSH provides related science and hazardous-drug guidance.
- Joint Commission and CMS patient-safety concepts include National Patient Safety Goals such as patient identification and infection prevention that directly shape infusion workflows.
- State nurse practice acts and facility privilege/competency processes define who may insert which devices; practice only within licensed scope and validated competency.
- FDA device reporting concepts require elevating serious device-related adverse events and malfunctions through facility channels so public safety systems can act.
Documentation as a clinical and legal instrument
Quick Answer: Chart what you assessed, what you did, what the patient response was, complications, and teaching—accurately, timely, and never in advance. Documentation must support the clinical story and stand up under legal, regulatory, and quality review. Pair charting discipline with knowledge of OSHA, NIOSH, Joint Commission/CMS NPSG concepts, state nurse practice acts/scope, and FDA device reporting pathways.
If it was not documented, the legal and quality record often treats it as not done. Infusion nursing generates high-stakes documentation: consent and time-out elements, insertion details, tip confirmation, flush/lock, dressing changes, complication recognition, and patient education. Weak notes harm continuity and weaken defense if an adverse event is litigated or surveyed.
What to document in infusion practice
Insertion and procedure notes
Capture enough detail for another clinician to understand the event:
- Indication and ordered device/therapy context
- Consent verification / time-out / identity checks as required
- Site, laterality, vein or approach, ultrasound use when applicable
- Catheter type, gauge/French, length, number of lumens, lot/expiration when policy requires
- Number of attempts, aseptic technique, barriers used
- Blood return, flush ease, securement, dressing
- Tip confirmation method and result for central devices when applicable
- Patient tolerance, complications during procedure, specimens sent
- Post-procedure teaching and activity instructions
Ongoing assessment and maintenance
Document site condition, dressing integrity, patency, infusion tolerance, pump settings when relevant, and any interventions (declotting algorithms started, dressing change, culture draws). When a complication occurs—infiltration, extravasation, phlebitis, occlusion, suspected CLABSI, air embolism—record time of recognition, signs, immediate actions, who was notified, orders received, and response. Vague phrases like “tolerated well” without supporting assessment are weak when the site later shows injury.
Teaching documentation
Record topics taught (device care, infection signs, when to call), learner (patient/caregiver), method, materials, teach-back outcome, and need for reinforcement. Home infusion discharge teaching is a frequent survey and liability focus.
Legal defensibility and charting discipline
Do not chart ahead. Pre-documenting assessments, flushes, or “procedure completed” before the act is dishonest and legally dangerous if the plan changes or an adverse event intervenes. Additional rules of thumb:
- Chart promptly after care so details are accurate
- Use objective language (“3 cm erythematous area proximal to site”) over judgmental labels
- Correct errors per facility policy (single-line strike, late entry)—never obliterate or invent
- Do not alter records to hide mistakes; follow just-culture reporting and amendment policies
- Avoid copying forward stale assessments that no longer match the patient
- Include notification of providers when findings require escalation
Contemporaneous, factual notes protect patients (continuity) and nurses (truthful account of care).
OSHA: workplace safety for infusion nurses
OSHA (Occupational Safety and Health Administration) sets enforceable workplace safety rules. High-yield infusion intersections:
Bloodborne pathogens standard
- Exposure control plans, universal/standard precautions framing for blood and OPIM
- Engineering controls (sharps with safety features), work-practice controls, PPE
- Hepatitis B vaccination programs, post-exposure evaluation pathways
- Proper handling of blood specimens and contaminated sharps
Sharps safety
- Use of safer medical devices when available and effective
- No recapping contaminated needles with two-handed technique
- Immediate disposal into puncture-resistant sharps containers; do not overfill
- Participation in device evaluation processes when employers select safer sharps
Hazardous drugs
Infusion nurses who handle antineoplastics and other hazardous drugs work under facility hazardous-drug programs informed by OSHA expectations and NIOSH hazardous-drug lists/recommendations (closed-system transfer devices where required, PPE, medical surveillance concepts, spill response). Know that workplace exposure control is separate from—but parallel to—patient extravasation management.
NIOSH role (high-level)
NIOSH (National Institute for Occupational Safety and Health) is a research and recommendations body (within CDC) rather than the primary enforcer like OSHA. For CRNI study, associate NIOSH with scientific guidance on hazardous drugs, sharps injury prevention research, and occupational risk reduction that employers use to build safer programs. Exam items may pair “NIOSH list of hazardous drugs” with PPE/CSTD practice.
Joint Commission, CMS, and National Patient Safety Goals
The Joint Commission (accreditation) and CMS (Conditions of Participation / quality programs for many settings) drive organizational patient-safety requirements. Infusion-relevant National Patient Safety Goal (NPSG) concepts include:
- Patient identification — two identifiers before procedures, treatments, and transfusions
- Infection prevention — hand hygiene, multidrug-resistant organism and CLABSI-related prevention expectations in applicable programs, safe injection practices culture
- Communication and medication safety themes that interact with labeling, anticoagulation, and reconciliation workflows
You do not need to memorize every annual NPSG number, but you must recognize that identity verification and infection prevention are accreditation-level expectations, not optional unit preferences. Policy, competencies, and audits exist because surveyors and payers expect measurable compliance.
State nurse practice acts and insertion privileges
Scope of practice is defined by state nurse practice acts and board of nursing rules, then operationalized by employer policy and privilege/competency systems. Implications:
- RN insertion of PICCs, midlines, or other devices requires education, competency validation, and facility authorization—certification alone (including CRNI®) does not automatically grant every procedural privilege everywhere
- Practice across state lines (compact considerations, telehealth, travel nursing) still requires adherence to the law of the state where the patient is located and the employer’s credentialing
- Delegating infusion tasks to unlicensed personnel is limited by state law and facility policy—know what cannot be delegated
- If ordered practice exceeds your validated competency, do not proceed; obtain a qualified inserter and escalate
Exam mindset: license + competency + order/policy alignment. Missing any leg is unsafe.
FDA device reporting concepts (high-level)
The FDA oversees medical device safety. When a vascular access device, pump, set, or related product malfunctions or is associated with serious injury or death, facilities follow internal risk/safety procedures that may include FDA MedWatch / medical device reporting obligations for manufacturers and certain user facilities. For the bedside CRNI candidate:
- Save the device when safe and policy directs (do not discard a suspected defective pump cassette or fractured catheter fragment carelessly)
- Document lot numbers, model, and event facts
- Report through the chain (charge nurse, risk management, biomedical engineering) promptly
- Understand that reporting protects future patients—not only the current case
You are not expected to litigate FDA regulatory subsections on the exam, but you should choose actions that preserve evidence, report, and remove defective equipment from use.
Integrating documentation with regulatory thinking
A single PICC insertion day may touch every layer: two-identifier NPSG compliance, consent documentation, sterile technique, OSHA bloodborne/sharps practices, competency within state scope, accurate procedure note, and—if the catheter cracks on insertion—device sequestering and safety reporting. Professional practice means seeing the system, not only the vein.
Quick compliance checklist for shifts
- Chart in real time; never pre-chart completed care
- Use two identifiers; document verification when required
- Activate safety devices; dispose of sharps correctly; use PPE/CSTDs for hazardous drugs
- Stay inside validated insertion privileges and state scope
- Escalate device failures with lot numbers and intact evidence when possible
These habits convert legal and regulatory frameworks into everyday safe infusion nursing.
Which documentation practice is legally and professionally unacceptable?
Which agency primarily enforces workplace standards such as the bloodborne pathogens rule and sharps injury prevention expectations for healthcare employers?
A nurse new to a facility holds CRNI® but has not completed that hospital’s PICC competency validation. A PICC is ordered. What is the correct action?
Which pair correctly matches a regulatory/accreditation concept to infusion practice?